Merck & Co., Inc. (MRK) — closed signal from December 13, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on March 13, 2026.
Predicted vs. what happened
What happened
Reached its target in 26 days.
The thesis — published December 13, 2025
Merck looks like a short-term bounce trade. The stock is unusually weak now (an oversold reading) but lots of trading is happening, and analysts see a reversal pattern. A favorable recommendation from the European regulator on WINREVAIR could improve sentiment. Because the company has weaker fundamentals, treat this as a short swing trade, not a long-term re-rating.
Primary drivers
- Price readings suggest a short-term rebound window
- EU label expansion for WINREVAIR can boost sentiment
- Heavy trading may indicate selling exhaustion then buying
- Large-cap pharma status helps reduce downside risk
How it played out
MRK: target reached in 26 days
Lyra published MRK at $100.3 on 2025-12-13 as a short-term bounce trade. The thesis expected 12% growth and pointed to weak price readings, heavy trading, a possible sentiment lift from WINREVAIR in Europe, and large-cap pharma status. It also warned that this was a swing trade, not a long-term re-rating.
Inside the window, MRK reached the $112.34 target in 26 days. It kept rising to a $125.14 peak on 2026-02-25, a 24.8% gain. By 2026-03-13, it ended at $115.61. The thesis played out and exceeded its target.
What happened during the window
On February 3, 2026, MarketWatch reported that Merck gave 2026 revenue guidance of $65.5 billion to $67.0 billion and adjusted earnings guidance of $5.00 to $5.15. It also reported fourth-quarter 2025 revenue of $16.4 billion and adjusted earnings of $2.04.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.